young people, have you fully or almost fully reversed significant thinning with meds alone?
    Chat 4/8/2026

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this question or advice post, the primary subjects mentioned are
    💊 Finasteride (oral) 2 months
    💧 Minoxidil (topical) 2 weeks
    💊 Dutasteride (oral)
    the tone is 😞 negative.

    Other terms

    A 20-year-old male experiencing significant hair loss started using finasteride and minoxidil, considering switching to dutasteride, and seeking encouragement from others who have seen improvements. Other users shared their experiences with similar treatments, noting improvements in hair coverage and stability, with some considering hair transplants as a future option.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Management of androgenetic alopecia: a review

      January 2021 in “International Journal of Research in Dermatology”
      This source reviews treatments for androgenetic alopecia, highlighting that combining therapies generally improves effectiveness over single treatments, and discusses emerging drug-assisted delivery techniques aimed at increasing the efficiency of conventional drugs like minoxidil and finasteride.
      Androgenetic Alopecia: Causes, Treatments, and Genetic Factors

      research Androgenetic Alopecia

      1 citations , July 2018 in “Elsevier eBooks”
      This review covers androgenetic alopecia's epidemiology, pathogenesis, current management options, and research trends, concluding that no definitive cure exists despite extensive interest and ongoing genetic research efforts.
      Androgenetic Alopecia: An Update

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
      Androgenic Alopecia Updates

      research Androgenic alopecia updates

      July 2023 in “International journal of dermatology, venereology and leprosy sciences”
      This review discusses the increased prevalence of androgenic alopecia in men and women, highlighting the limited FDA-approved treatment options, and reports no clinical results; the authors note adherence challenges due to prolonged drug use.